Unbiased screening of polymer libraries to define novel substrates for functional hepatocytes with inducible drug metabolism.
about
Human pluripotent stem cells for modelling human liver diseases and cell therapyStem cell differentiation and human liver diseasePluripotent stem cell derived hepatocytes: using materials to define cellular differentiation and tissue engineeringCell microenvironment engineering and monitoring for tissue engineering and regenerative medicine: the recent advances.Concise review: Human pluripotent stem cell-based models for cardiac and hepatic toxicity assessment.Establishment of automated culture system for murine induced pluripotent stem cellsConcise review: workshop review: understanding and assessing the risks of stem cell-based therapiesRobust generation of hepatocyte-like cells from human embryonic stem cell populations.Analysis and prediction of defects in UV photo-initiated polymer microarrays.Stem cells in liver diseases and cancer: recent advances on the path to new therapies.Discovery of a Novel Polymer for Human Pluripotent Stem Cell Expansion and Multilineage DifferentiationRecombinant Laminins Drive the Differentiation and Self-Organization of hESC-Derived HepatocytesA defined synthetic substrate for serum-free culture of human stem cell derived cardiomyocytes with improved functional maturity identified using combinatorial materials microarrays.Polymer microarray technology for stem cell engineering.Reducing Hepatocyte Injury and Necrosis in Response to Paracetamol Using Noncoding RNAs.Microarrayed Materials for Stem Cells.Comparisons between in vitro whole cell imaging and in vivo zebrafish-based approaches for identifying potential human hepatotoxicants earlier in pharmaceutical development.Liver tissue engineering and cell sources: issues and challenges.Constructing stem cell microenvironments using bioengineering approaches.Modeling human liver biology using stem cell-derived hepatocytes.Assembly of human organs from stem cells to study liver disease.Cell and tissue engineering for liver disease.Preparing the ground for tissue regeneration: from mechanism to therapy.Highly Synchronized Expression of Lineage-Specific Genes during In Vitro Hepatic Differentiation of Human Pluripotent Stem Cell Lines.Concise Review: Advances in Generating Hepatocytes from Pluripotent Stem Cells for Translational Medicine.Human hepatocytes derived from pluripotent stem cells: a promising cell model for drug hepatotoxicity screening.Phenotypic and functional analyses show stem cell-derived hepatocyte-like cells better mimic fetal rather than adult hepatocytes.Stabilizing hepatocellular phenotype using optimized synthetic surfaces.Modulating innate immunity improves hepatitis C virus infection and replication in stem cell-derived hepatocytes.Developing high-fidelity hepatotoxicity models from pluripotent stem cellsAccurate prediction of drug-induced liver injury using stem cell-derived populations.Maintaining hepatic stem cell gene expression on biological and synthetic substrataHigh-throughput Identification of Bacteria Repellent Polymers for Medical Devices.Three-dimensional culture and cAMP signaling promote the maturation of human pluripotent stem cell-derived hepatocytes.SUMOylation of HNF4α regulates protein stability and hepatocyte function.The complexities of engineering human stem cell-derived therapeutics.Synthetic Biomaterials to Rival Nature's Complexity-a Path Forward with Combinatorics, High-Throughput Discovery, and High-Content Analysis.Comparative transcriptomics of hepatic differentiation of human pluripotent stem cells and adult human liver tissue.Human induced pluripotent stem cell-derived hepatocytes for toxicology testing.Mass production of stem cell derived human hepatocytes for experimental medicine.
P2860
Q27005360-A2F1BBD1-8ABB-419C-BDB2-2CD1FE948FDEQ27027529-9A4F45B9-0789-4C83-9802-44C8CC1608B8Q28076413-52380696-AC14-45A6-8B7D-4D14B3E59D2FQ34014077-25544194-5FD3-46AF-98E7-F5762AE23B97Q34172962-9F2B1A26-DC67-446F-A090-7796A27EF726Q34467541-622B1978-236C-4FF5-81B4-FE5EF6B50C6EQ35200156-5CA5DB44-9E2D-4C02-AFA5-810EB9E9A62CQ35581841-D122C895-BF07-4BED-871F-5FC7C9D2205DQ35583548-73F39613-369D-4967-9CDE-1646A3420FCEQ35631841-62D515F5-AFC4-4ED3-A830-5E57B0814198Q35649217-22090904-F260-469C-9539-838C708EDD6EQ36379726-EF63F081-5419-4137-85E0-4E9ECA6EA47CQ36657749-9EDDA996-5520-47EA-8B9B-B536E73E54C1Q36739592-A6A4874C-5997-4467-A0F4-DB3B75819489Q36930476-66E26BB3-899A-45A7-A3F4-57D0118F6D6FQ37360289-BA41CB6A-7445-439D-8B6A-643C0A110804Q37975546-FCC79CC5-5D9E-49D7-A11D-E735701DED0EQ38089346-9ACA9320-7D28-476F-BD26-44FFF9E35489Q38142559-FEECD81A-8A4D-48F8-9D50-8A99F9AA09AAQ38160662-E847ADA4-3033-4035-8A67-16CFC44FA80EQ38170868-FF48732B-DC29-40E0-BF1D-4A49C07E7B6AQ38230357-F579BEED-63FF-467E-A48C-053BBBF78F10Q38237617-90B9AFCE-6195-47BC-96D4-A6B984E629DCQ38426877-93378135-CC03-4E93-8D9C-9252C202B870Q38789231-5E425571-1105-4CFF-BE8B-CA6C12F9D77CQ38871403-BE9194CE-61F4-4721-ABB6-B0728E04BD32Q38933941-1D8C754B-6F93-4795-98D6-FED765D62082Q38950311-4AF06D37-4A8E-4A5C-896E-CB1F3854A17DQ38971157-9A95E623-92FE-4693-9D4E-0D3F177749B8Q39140743-5736DAC7-643D-4F62-839E-51A2FC7E9AA9Q39283236-42FA17E7-F86D-4022-B3BA-9308EEF159D0Q39420288-F32D8EC5-8F20-4CA9-A0C6-DB558F8F1F3DQ40452861-EB128C3E-D525-47D4-BEEB-E625E318F090Q41433197-F229F606-A2A6-40A9-BCDF-A487039D94D9Q42115226-6C2764B8-AE79-49E1-B7FC-91CBB5FFC9FBQ42709719-890F791F-F19C-4DE2-8DF7-64385360054AQ47753635-59E2B6DD-F0A7-43F1-ACE9-A0E3F9C55BA2Q48143410-CBD82803-7AB0-4844-AFA9-5FE5EE2A9BFBQ48716931-4618BF24-3DA2-4798-B8D2-C6461D886651Q50515841-B0AFB41F-6337-4061-8CF4-CC0CBEB9CA78
P2860
Unbiased screening of polymer libraries to define novel substrates for functional hepatocytes with inducible drug metabolism.
description
2010 nî lūn-bûn
@nan
2010 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Unbiased screening of polymer ...... ith inducible drug metabolism.
@ast
Unbiased screening of polymer ...... ith inducible drug metabolism.
@en
type
label
Unbiased screening of polymer ...... ith inducible drug metabolism.
@ast
Unbiased screening of polymer ...... ith inducible drug metabolism.
@en
prefLabel
Unbiased screening of polymer ...... ith inducible drug metabolism.
@ast
Unbiased screening of polymer ...... ith inducible drug metabolism.
@en
P2093
P50
P1433
P1476
Unbiased screening of polymer ...... ith inducible drug metabolism.
@en
P2093
Alexandra I Thompson
Claire N Medine
David C Hay
Donna Dalgetty
James A Ross
James R Black
Joerg Schrader
John P Iredale
Judy Fletcher
Mark Bradley
P304
P356
10.1016/J.SCR.2010.12.002
P577
2010-12-10T00:00:00Z